148 related articles for article (PubMed ID: 10082661)
1. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
Rao CN; Mohanam S; Puppala A; Rao JS
Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
[TBL] [Abstract][Full Text] [Related]
2. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
3. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
4. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
[TBL] [Abstract][Full Text] [Related]
5. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
6. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.
Rao CN; Cook B; Liu Y; Chilukuri K; Stack MS; Foster DC; Kisiel W; Woodley DT
Int J Cancer; 1998 May; 76(5):749-56. PubMed ID: 9610735
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
8. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen.
Moilanen M; Sorsa T; Stenman M; Nyberg P; Lindy O; Vesterinen J; Paju A; Konttinen YT; Stenman UH; Salo T
Biochemistry; 2003 May; 42(18):5414-20. PubMed ID: 12731883
[TBL] [Abstract][Full Text] [Related]
10. Activation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase.
Takeda M; Imada K; Sato T; Ito A
Biochem Biophys Res Commun; 2000 Feb; 268(1):128-32. PubMed ID: 10652225
[TBL] [Abstract][Full Text] [Related]
11. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells.
Devy L; Noël A; Baramova E; Bajou K; Trentesaux C; Jardillier JC; Foidart JM; Jeannesson P
Biochem Biophys Res Commun; 1997 Sep; 238(3):842-6. PubMed ID: 9325178
[TBL] [Abstract][Full Text] [Related]
12. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
13. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
Ogata Y; Itoh Y; Nagase H
J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
[TBL] [Abstract][Full Text] [Related]
16. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
17. Membrane independent activation of fibroblast proMMP-2 by snake venom: novel roles for venom proteinases.
Saravia-Otten P; Frisan T; Thelestam M; Gutiérrez JM
Toxicon; 2004 Dec; 44(7):749-64. PubMed ID: 15500851
[TBL] [Abstract][Full Text] [Related]
18. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.
Sato T; Sawaji Y; Matsui N; Sato H; Seiki M; Mori Y; Ito A
Biochem Biophys Res Commun; 1999 Nov; 265(1):189-93. PubMed ID: 10548512
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
20. Methods for studying activation of matrix metalloproteinases.
Knäuper V; Murphy G
Methods Mol Biol; 2010; 622():233-43. PubMed ID: 20135286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
